StreetAlpha.app
Home › Stocks › TVRD

Tvardi Therapeutics, Inc. (TVRD)

$0.99
▲ +4.57%
LAST CLOSE · NOV 20

Tvardi develops oral small molecule drugs that inhibit STAT3 to treat inflammatory and proliferative diseases. It last closed at $0.99 on Nov 20, up 4.57% on the day. The next earnings report for TVRD is expected around Tue, Mar 30, 2027, after the close. For the quarter ended Sep 2026, TVRD reported EPS of -$0.48. Over its last 8 reports the stock moved an average of 2.9% the session after earnings.

AI Auto Pilots
Is TVRD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TVRD.

Key Stats

Last 12 months
Results
Net income
−$26.7M
EPS (diluted)
−$2.61
Valuation
Market cap
$13.2M
13.4M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.3M
At Sep 30
Shareholder equity
$15.5M
Shares outstanding
13.4M
At Nov 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$88.4M−$88.4MFY2021FY2022: −$85.5M−$85.5MFY2022FY2023: −$118.5M−$118.5MFY2023FY2024: −$29.4M−$29.4MFY2024FY2025: −$18.2M−$18.2MFY2025

From TVRD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 13). Last 12 months adds up the four latest quarters.

Next report
Mar 30
Estimated date · After the close
Reported EPS
-$0.48
Quarter ended Sep 2026
Year ago EPS
-$0.59
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$4.94Dec '24Mar 2025: -$3.72Mar '25Jun 2025: -$1.00Jun '25Sep 2025: -$0.59Sep '25Dec 2025: -$0.76Dec '25Mar 2026: -$0.73Mar '26Jun 2026: -$0.69Jun '26Sep 2026: -$0.48Sep '26Latest -$0.48
Revenue by quarter
Not enough quarters on file yet.
How TVRD moved after its last 8 reports
Average move the session after a report ±2.9%
Nov 13, 2026Time not announced+2.2%
Aug 14, 2026Time not announced+7.3%
May 8, 2026Time not announced−0.7%
Mar 31, 2026After the close−5.7%
Nov 13, 2025After the close−1.9%
Aug 14, 2025After the close+0.9%
May 13, 2025After the close−0.7%
May 13, 2024After the close−3.6%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on TVRDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
Analyst calls from around the web
Last 90 days on TVRD: 0 upgrades, 0 downgrades, 0 initiations
HC WainwrightReiterated
Nov 21Buy 

StreetAlpha's curated list of analyst calls collected from around the web. It may be incomplete or inaccurate, is not a consensus and is not advice.

AI Starter and AI Pro
Full analyst coverage on TVRD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on TVRD

Technical Analysis

TVRD · as of the Nov 20 close · updated each morning
Downtrend

The stock is 2% below its 20 day and 16% below its 50 day average. It is 155% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 45). The nearest support is the swing low (Oct 12) at $0.97, and the nearest resistance the 20 day average at $1.01.

Short trendBearish
Long trendBearish
MomentumNeutral
StretchNormal
VolatilityHigh, 14.9%/day
Key levels
$5.6952 week high+474.7%
$2.52200 day average+154.5%
$1.71100 day average+72.7%
$1.1550 day average+16.2%
$1.09Swing high (Oct 21)+10.1%
$1.03Pivot R1+4.0%
$1.0120 day average+2.0%
$0.99Last close
$0.97Swing low (Oct 12)−2.0%
$0.96Pivot−3.0%
$0.93Pivot S1−6.1%
$0.7752 week low−22.2%
Indicators
RSI (14)45.32Middle of its rangeNeutral
MACD-0.02Below its signal lineBearish
Stochastic24.9Middle of its rangeNeutral
ADX (14)32.3Trending up
Williams %R-76.3Oversold below −80, overbought above −20Neutral
CCI (20)-20.8Oversold below −100, overbought above 100Neutral
Rate of change+3.3%Change over 10 sessionsBullish
ATR (14)$0.15Typical daily range, 14.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TVRD

What happened before

See how TVRD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow TVRD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How TVRD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for TVRDHow many large options trades hit TVRD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

TVRD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲36 buying vs 29 selling
  • ▲Held by funds +10.4 pts
  • ▲Funds holding +2
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding6260+3.3%
In funds' top 1000–
Held by funds27.1%16.7%+10.4 pts
New / increased21 / 1513 / 6+89.5%
Reduced / sold out11 / 1823 / 20−32.6%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TVRD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TVRD is in one of them and how their past TVRD trades turned out.

TVRD in the AI portfolios
Loading…

TVRD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TVRD in an article yet. Here's the latest on the wider market.

TVRD in the news

About Tvardi Therapeutics

Tvardi is a biopharmaceutical company based in Sugar Land, Texas. It is developing oral, small molecule drugs that aim to block STAT3, a protein inside cells that drives inflammatory and cell growth diseases. Its TTI-101 candidate is being tested in patients with liver cancer and has also been studied in idiopathic pulmonary fibrosis, a lung disease. The company does not yet sell products, and its drugs are still in clinical trials.

Headquarters
Sugar Land, TX